It was found in the present study that elevated IL-6 levels were significantly associated with an increased risk of poor outcomes (205.50±675.47 in deceased versus 117.37±279.23 in discharged; p<0.05) among COVID-19 patients. The gene discussed is IL6; the disease is COVID-19.